Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | STVN Stevanato Group S.p.A. | ABBV AbbVie |
|---|---|---|
| Price | $20.20 +1.1% | $262.82 +1.1% |
| StockIQ Score | 39F Weak Risk: High | 46D+ Moderate Risk: High |
| Technical | 31F | 35F |
| Fundamental | — | 57C |
| Growth | — | 34F |
| Fair Value | — | 33F |
| News | 62C+ | 98A+ |
| Quality | — | 42D |
| Risk | 34F | 44D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AbbVie (ABBV) outperforms Stevanato Group (STVN) in nearly every category. Its investor score (46 vs. 39) and technical score (35 vs. 31) are higher, and it has strong fundamental (57), growth (34), and valuation (33) scores where data exists. Stevanato’s rating is weaker, and its other scores are unavailable, making AbbVie the stronger choice based on available metrics.
